SCHEMBL24310318

SCHEMBL24310318

CN1CCN(c2ccc(Oc3cc(-c4ccccc4)nc(NSc4cnn(C)c4)n3)cc2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 4/20 0.42
▸ HRH4 Q9H3N8 5/20 0.41
▸ HRH1 P35367 4/20 0.41
▸ MELK Q14680 1/20 0.41
▸ HRH2 P25021 1/20 0.39
▸ HRH3 Q9Y5N1 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ XBP1 P17861 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KLF5 Q13887 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HTR3A P46098 1/20 0.36
▸ ALK Q9UM73 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ KDM1A O60341 2/20 0.35
▸ TNK2 Q07912 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309688 0.89 MAPK1 (0.46) HRH4HRH1HRH2HRH3KDM4E
SCHEMBL24310524 0.85 BRD4 (0.37) —
SCHEMBL24310306 0.84 CDK4 (0.34) MAP4K1HRH4MELKALK
SCHEMBL24309807 0.83 CDK4 (0.33) MAP4K1NPC1MAPTRAB9AALK
SCHEMBL24310517 0.82 CDK4 (0.33) MAP4K1HRH4
SCHEMBL24310329 0.82 MET (0.32) MAP4K1KDM1A
SCHEMBL24310325 0.82 MAP4K1 (0.32) MAP4K1NPC1MAPTRAB9AALK
SCHEMBL26826527 0.81 HRH1 (0.42) MAP4K1HRH4HRH1MELKHRH2
SCHEMBL24309676 0.80 FLT3 (0.38) MAP4K1
SCHEMBL24310202 0.80 PLK4 (0.38) MAP4K1KDM4EALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback